Parrish Capital’s bioAffinity Technologies BIAF Stock Holding History

Parrish Capital’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-695	Closed	-$8.46K	–	85
2026 Q2	$8.46K	Buy	+695	New	+$21.3K	0.01%	87

Other funds holding BIAF

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Parrish Capital's BIAF Position: Q3 2026 in Review

Parrish Capital sold out of bioAffinity Technologies (BIAF) in Q3 2026, closing a stake of 695 shares — an estimated $8.46K sold.

Parrish Capital first reported a position in BIAF in Q2 2026 and held it in 1 quarter. The position peaked at $8.46K in Q2 2026. 1 fund tracked by Wall St. Rank holds BIAF as of Q3 2026.

Parrish Capital reported no remaining bioAffinity Technologies position as of Q3 2026 after selling out during the quarter.
Parrish Capital sold 695 bioAffinity Technologies shares in Q3 2026, an estimated $8.46K.
Parrish Capital first reported a position in bioAffinity Technologies in Q2 2026 and held it in 1 quarter.
Parrish Capital's bioAffinity Technologies position peaked at $8.46K in Q2 2026.
1 fund tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.